The number of people with susceptibility test result for rifampicin in Bhutan
Bhutan: The number of people with susceptibility test result for rifampicin was 419 in 2021. ▲ Rising
Latest (2021)
419
Change on year
down 3.5%
World rank
83rd
of 155 countries
All-time high
476
in 2019
All-time low
349
in 2018
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Bhutan, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for the number of people with susceptibility test result for rifampicin in Bhutan is 419, measured in 2021.
The figure is down 3.5% on the previous year and up 11.4% over five years.
Bhutan ranks 83rd of 155 countries on this measure, in the middle of the range.
The number of people with susceptibility test result for rifampicin in Bhutan, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 376 | — |
| 2018 | 349 | -7.2% |
| 2019 | 476 | +36.4% |
| 2020 | 434 | -8.8% |
| 2021 | 419 | -3.5% |
Bhutan compared with similar countries
- Bhutan's 419 is below the median for lower middle income countries, which is 2,804, 15% of the median. (32 countries reporting)
- Bhutan's 419 is below the median for South Asia, which is 11,863, 4% of the median. (5 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 400.33 | 349 | 476 | 3 |
| 2020s | 426.5 | 419 | 434 | 2 |
Countries ranked near Bhutan
More health data for Bhutan
- Un projection of annual infant deaths, annual growth rate -10 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.0915 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,531 deaths per 1,000 people (2090)
- Number of infants who die before age 1 9 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate 0.2986 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0299 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.3987 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Bhutan?
- The number of people with susceptibility test result for rifampicin in Bhutan was 419 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Bhutan?
- The highest recorded value was 476 in 2019.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Bhutan?
- The lowest recorded value was 349 in 2018.
- How does Bhutan rank for the number of people with susceptibility test result for rifampicin?
- Bhutan ranks 83rd out of 155 countries with data for 2021.
- Where does this Bhutan data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).